» Articles » PMID: 38681798

Navigating the Outcome Maze: a Scoping Review of Outcomes and Instruments in Clinical Trials in Genetic Neurodevelopmental Disorders and Intellectual Disability

Abstract

Background: Individuals with genetic neurodevelopmental disorders (GNDs) or intellectual disability (ID) are often affected by complex neuropsychiatric comorbidities. Targeted treatments are increasingly available, but due to the heterogeneity of these patient populations, choosing a key outcome and corresponding outcome measurement instrument remains challenging.

Objectives: The aim of this scoping review was to describe the research on outcomes and instruments used in clinical trials in GNDs and ID.

Eligibility Criteria: Clinical trials in individuals with GNDs and ID for any intervention over the past 10 years were included in the review.

Sources Of Evidence: MEDLINE, PsycINFO, and Cochrane CENTRAL were searched. Titles and abstracts were independently screened for eligibility with a subsample of 10% double-screening for interrater reliability. Data from full texts were independently reviewed. Discrepancies were discussed until consensus was reached.

Charting Methods: Information was recorded on patient populations, interventions, designs, outcomes, measurement instruments, and type of reporter when applicable. Qualitative and descriptive analyses were performed.

Results: We included 312 studies reporting 91 different outcomes, with cognitive function most frequently measured (28%). Various outcome measurement instruments ( = 457) were used, with 288 in only a single clinical trial. There were 18 genetic condition-specific instruments and 16 measures were designed ad-hoc for one particular trial. Types of report included proxy-report (39%), self-report (22%), clinician-report (16%), observer-report (6%), self-assisted report (1%), or unknown (16%).

Conclusion: This scoping review of current practice reveals a myriad of outcomes and outcome measurement instruments for clinical trials in GNDs and ID. This complicates generalization, evidence synthesis, and evaluation. It underlines the need for consensus on suitability, validity, and relevancy of instruments, ultimately resulting in a core outcome set. A series of steps is proposed to move from the myriad of measures to a more unified approach.

Citing Articles

Prioritisation of head, neck, and respiratory outcomes in mucopolysaccharidosis type II: lessons from a rare disease consensus exercise and comparison of parental and clinical priorities.

Dempsey J, Daniels J, Katiri R, Thomas S, Metryka A, de Kruijf M Orphanet J Rare Dis. 2025; 20(1):88.

PMID: 40011961 PMC: 11866613. DOI: 10.1186/s13023-025-03581-y.


PROs for RARE: protocol for development of a core patient reported outcome set for individuals with genetic intellectual disability.

van Silfhout N, van Muilekom M, van Karnebeek C, Haverman L, Van Eeghen A Orphanet J Rare Dis. 2024; 19(1):354.

PMID: 39334201 PMC: 11428331. DOI: 10.1186/s13023-024-03264-0.

References
1.
Luijten M, van Litsenburg R, Terwee C, Grootenhuis M, Haverman L . Psychometric properties of the Patient-Reported Outcomes Measurement Information System (PROMIS®) pediatric item bank peer relationships in the Dutch general population. Qual Life Res. 2021; 30(7):2061-2070. PMC: 8233291. DOI: 10.1007/s11136-021-02781-w. View

2.
Janssen C, Schuengel C, Stolk J . Perspectives on quality of life of people with intellectual disabilities: the interpretation of discrepancies between clients and caregivers. Qual Life Res. 2005; 14(1):57-69. DOI: 10.1007/s11136-004-1692-z. View

3.
Valderas J, Alonso J . Patient reported outcome measures: a model-based classification system for research and clinical practice. Qual Life Res. 2008; 17(9):1125-35. DOI: 10.1007/s11136-008-9396-4. View

4.
Ingerski L, Modi A, Hood K, Pai A, Zeller M, Piazza-Waggoner C . Health-related quality of life across pediatric chronic conditions. J Pediatr. 2010; 156(4):639-44. PMC: 3115583. DOI: 10.1016/j.jpeds.2009.11.008. View

5.
Bakkum L, Paalman C, Muller A, van Eeghen A, Schuengel C . Accessibility and feasibility of experience sampling methods for mental health research with people with intellectual disability: Scoping of research and stakeholder views. J Appl Res Intellect Disabil. 2024; 37(2):e13190. DOI: 10.1111/jar.13190. View